Blue Owl, a direct lender specializing in loans to the software industry, said it had sold $1.4 billion of its loans to institutional investors at 99.7% of par value.
With Trump’s ‘reciprocal’ tariffs struck down, here are the industries still facing higher rates
President Donald Trump’s so-called “reciprocal” tariffs were deemed unconstitutional by the Supreme Court, but some sector-specific tariffs remain in place.
Equinox’s $40,000-a-year membership has a waiting list, says chairman Harvey Spevak
Harvey Spevak, Equinox’s executive chairman, said demand for “Optimize” memberships highlights the “insatiable” demand by the wealthy for wellness offerings.
Fourth-quarter U.S. GDP up just 1.4%, badly missing estimate; inflation firms at 3%
The core PCE price index was expected to increase 3% from a year ago in December. GDP was projected to rise at a 2.5% pace in Q4.
Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more
These are the stocks posting the largest moves in premarket trading.
Stocks making the biggest moves after hours: Akamai Technologies, Opendoor, Live Nation & more
These are the stocks posting the largest moves in extended trading.
Life after the Great Resignation: Incentives are dimming for workers to change jobs
The disparity between average annual pay increases for those staying in their jobs against those leaving has all but collapsed.
U.S. trade deficit totaled $901 billion in 2025 despite Trump’s tariffs
The U.S. trade deficit swelled in December, closing out a year in which the imbalance was essentially unchanged.
Stocks making the biggest moves premarket: Walmart, Hims & Hers, Carvana, Figma & more
These are the stocks posting the largest moves in the premarket.
Inside Wealth: Equinox’s Harvey Spevak on why health is the new luxury
CNBC Wealth Editor Robert Frank speaks exclusively with Equinox Executive Chairman Harvey Spevak about the global wellness market and why the wealthy are shifting their spending to focus on longevity and health.